Advances in diagnosis and treatment of metastatic cervical cancer

H Li, X Wu, X Cheng - Journal of gynecologic oncology, 2016 - synapse.koreamed.org
Cervical cancer is one of the most common cancers in women worldwide. The outcome of
patients with metastatic cervical cancer is poor. We reviewed the relevant literature …

Oligometastases and oligo-recurrence: the new era of cancer therapy

Y Niibe, K Hayakawa - Japanese journal of clinical oncology, 2010 - academic.oup.com
Recurrence or metastasis of cancer has been considered to occur in the last stage of the
patient's life. However, the new notions of oligometastases and oligo-recurrence have been …

Elucidating the role of tumor-associated ALOX5+ mast cells with transformative function in cervical cancer progression via single-cell RNA sequencing

F Zhao, J Hong, G Zhou, T Huang, Z Lin… - Frontiers in …, 2024 - frontiersin.org
Background Cervical cancer (CC) is the fourth most common malignancy among women
globally and serves as the main cause of cancer-related deaths among women in …

Mapping pelvic lymph nodes: guidelines for delineation in intensity-modulated radiotherapy

A Taylor, AG Rockall, RH Reznek… - International Journal of …, 2005 - Elsevier
Purpose: To establish guidelines for delineating the clinical target volume for pelvic nodal
irradiation by mapping the location of lymph nodes in relation to the pelvic anatomy …

Association of posttherapy positron emission tomography with tumor response and survival in cervical carcinoma

JK Schwarz, BA Siegel, F Dehdashti, PW Grigsby - Jama, 2007 - jamanetwork.com
ContextRetrospective studies have demonstrated that the use of positron emission
tomography (PET) with F-18 fluorodeoxyglucose (FDG) in the posttherapy evaluation of …

Follow-up for women after treatment for cervical cancer: a systematic review

L Elit, AW Fyles, MC Devries, TK Oliver… - Gynecologic …, 2009 - Elsevier
OBJECTIVE: To determine the optimal recommended program for the follow-up of patients
who are disease free after completed primary therapy for cervical cancer. METHODS …

Molecular landscape of recurrent cervical cancer

D Adiga, S Eswaran, D Pandey, K Sharan… - Critical Reviews in …, 2021 - Elsevier
Cervical cancer (CC) is a major gynecological problem in developing and underdeveloped
countries. Despite the significant advancement in early detection and treatment modalities …

The serum assay of tumour markers in the prognostic evaluation, treatment monitoring and follow-up of patients with cervical cancer: a review of the literature

A Gadducci, R Tana, S Cosio, AR Genazzani - Critical reviews in oncology …, 2008 - Elsevier
Pre-treatment serum squamous cell carcinoma antigen [SCC] levels are elevated in 28–88%
of patients with squamous cell cervical cancer, and are related to tumour stage, tumour size …

Cancer of the cervix uteri

E Wiebe, L Denny, G Thomas - International Journal of Gynecology & …, 2012 - Elsevier
Worldwide, cervical cancer is second only to breast cancer as the most common female
malignancy in both incidence and mortality, and results in approximately 275000 deaths …

[HTML][HTML] The association between serum squamous cell carcinoma antigen and recurrence and survival of patients with cervical squamous cell carcinoma: a …

C Charakorn, K Thadanipon, S Chaijindaratana… - Gynecologic …, 2018 - Elsevier
Objective The aim of this systematic review and meta-analysis was to pool association
effects of serum squamous cell carcinoma antigen (SCC-Ag) on recurrence and mortality in …